Literature DB >> 12841879

Factors affecting long-term adherence to hormone replacement therapy after screening for osteoporosis.

S A Steel1, P Albertazzi, E M Howarth, D W Purdie.   

Abstract

OBJECTIVE: To investigate factors likely to influence adherence to hormone replacement therapy (HRT) in women known to have low bone mass. STUDY
DESIGN: This was a prospective study of bone mineral density screening in 6282 women aged 50-54 years.
RESULTS: Low bone mass at either the hip or spine was found in 1462 women. The principal route of HRT delivery, transdermal or oral, as well as the presence of climacteric symptoms before starting treatment, did not influence adherence. However, adherence to HRT type was significantly superior in hysterectomized women taking unopposed estradiol (median 32 months) compared with those on sequential HRT (median 28 months; p = 0.011). Overall, a 5-year adherence to HRT of 61% was achieved.
CONCLUSION: Approximately 34% of women starting HRT are likely to stop in the first 2 years of use. Following this, the discontinuation rate is low. The combination of knowledge of risk for osteoporosis and regular follow-up positively influences long-term adherence to HRT.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12841879

Source DB:  PubMed          Journal:  Climacteric        ISSN: 1369-7137            Impact factor:   3.005


  4 in total

1.  Incidence and causes for failure of treatment of women with proven osteoporosis.

Authors:  Noah Zafran; Zvi Liss; Ronit Peled; Michael Sherf; Haim Reuveni
Journal:  Osteoporos Int       Date:  2005-04-02       Impact factor: 4.507

Review 2.  A systematic review of factors affecting medication adherence among patients with osteoporosis.

Authors:  C T Yeam; S Chia; H C C Tan; Y H Kwan; W Fong; J J B Seng
Journal:  Osteoporos Int       Date:  2018-11-12       Impact factor: 4.507

Review 3.  Patient adherence to osteoporosis medications: problems, consequences and management strategies.

Authors:  Alexandra Papaioannou; Courtney C Kennedy; Lisa Dolovich; Elaine Lau; Jonathan D Adachi
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

4.  The high bone mass phenotype is characterised by a combined cortical and trabecular bone phenotype: findings from a pQCT case-control study.

Authors:  Celia L Gregson; Adrian Sayers; Victor Lazar; Sue Steel; Elaine M Dennison; Cyrus Cooper; George Davey Smith; Jörn Rittweger; Jon H Tobias
Journal:  Bone       Date:  2012-10-24       Impact factor: 4.398

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.